Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT06965751
Description:
Individual participant data that underlie any published results, after deidentification (text, tables, figures, and appendices) will be shared. The Study Protocol and Informed Consent Form will also be made available. These data will be shared with Investigators whose proposed use of the data has been approved by an independent review committee, for the purpose of participant data meta-analysis. The data will be available 3 months after publication and ending 5 years following publication. Proposals should be directed to Professor Stephen Kent (skent@unimelb.edu.au). To gain access to the data, requestors will need to sign a data sharing agreement.
Study:
NCT06965751
Study Brief:
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19